3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Esophageal Neoplasms
9
Melanoma
6
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Carcinoma, Transitional Cell
2
Unresectable Biliary Tract Cancer
1
Thymus Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Small Cell Lung Cancer Extensive Stage
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pathologic Complete Response
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Nasopharyngeal Neoplasms
1
Muscle-Invasive Bladder Carcinoma
1
Interventions
Temozolomide
45
Radiotherapy
17
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Bevacizumab
12
pembrolizumab
11
Lomustine
9
Radiation
8
fludarabine
7
Cyclophosphamide
7
atezolizumab
4
Biopsy
4
olaparib
3
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Nivolumab
3
Leukapheresis
3
D2C7-(scdsFv)-PE38KDEL
3
Blood Specimen Collection
3
Aminolevulinic Acid
3
regorafenib
2
fluciclovine F-18
2
contrast agent BR1
2
antisecretory factor
2
abemaciclib
2
Restraint, Physical
2
Re-Irradiation
2
Radiation Dose Hypofractionation
2
Palliative Care
2
Oncolytic Virotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Glioblastoma
×
Immunotherapy
×
Clear all
NCT06283927
2024-02-28
RECSUR
Erasmus Medical Center
Recruiting
464 enrolled